| Financial Year |
September 30 2019 |
| Monetary Funds |
18,081,528,572.36 |
| Held-for-trading Financial Assets |
43,116,159,308.46 |
| Notes Receivable |
1,158,449.42 |
| Accounts Receivable |
1,269,561,436.38 |
| Advances to Suppliers |
308,658,325.78 |
| Other Receivables |
2,886,703,579.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
3,872,398.40 |
| Inventories |
61,547,277,616.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
16,686,706.54 |
| Other Current Assets |
7,027,245,309.41 |
| Total Current Assets |
141,905,436,993.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,850,539.01 |
| Long-term Equity Investment |
11,820,066,535.24 |
| Investment Properties |
11,419,197,635.09 |
| Fixed Assetes |
884,217,723.90 |
| Under-construction Projects |
2,839,082,879.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
117,600,504.35 |
| R&D expenses |
-- |
| Goodwill |
2,986,192,875.04 |
| Long-Term Deferred and Prepaid Expenses |
83,449,669.33 |
| Deferred Income Tax Assets |
2,820,904,431.71 |
| Other Non-Current Assets |
2,022,241,728.31 |
| Sub-Total of Non-Current Assets |
40,166,663,724.81 |
| Total Assets |
182,072,100,718.76 |
| Short-Term Loans |
16,979,088,002.65 |
| Trading Financial liabilities |
3,457,162,158.14 |
| Notes Payable |
-- |
| Accounts Payable |
5,659,094,640.41 |
| Accounts Received In Advance |
8,470,518,482.82 |
| Employee Compensation Payable |
1,206,851,619.29 |
| Taxes Payable |
3,094,890,549.83 |
| Interest Payable |
-- |
| Dividend Payable |
189,090,879.75 |
| Other payables |
10,374,720,938.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,133,585,252.42 |
| Other Current Liabilities |
2,967,072,996.80 |
| Sub-Total of Current Liabilities |
94,169,267,695.67 |
| Long-term Loans |
21,725,788,801.98 |
| Bonds Payable |
28,807,046,844.24 |
| Long-Term Accounts Payable |
1,846,718,456.66 |
| Special Payable |
-- |
| Estimatied Liabilities |
41,619,187.50 |
| Deferred Income Tax Liabilities |
1,377,439,594.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
53,798,612,884.42 |
| Total Liabilities |
147,967,880,580.09 |
| Paid-In Capital(Or Share Stock) |
5,196,200,656.00 |
| Capital Surplus |
6,971,373,011.22 |
| Surplus Reserve |
1,093,370,500.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,508,721,081.77 |
| Minority Stockholder's Interest |
11,207,280,588.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
22,896,939,550.19 |
| Owner's Equity（Stockholder's Equity） |
34,104,220,138.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
182,072,100,718.76 |
